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Une recherche qui veut changer notre compréhension de la 
pathologie du cancer du sein basée sur les théories de la physique 
quantique.  Si on comprend les anomalies subatomiques de 
presque tous les cancers du sein,. on sera en mesure d’améliorer 
les diagnostics et les traitements et d’offrir des alternatives 
non-toxiques à la chimiothérapie et à la radiation.  L’auteure 
vote en faveur de méthodes de dépistages moins à risques et 
davantage de tests cliniques. 
Robert L. Egan is credited with the development of mam-
mography equipment in the 1960s, some 50 years ago. 
The first commercial machine was available in 1965. The 
requirements for an acceptable technology at that time 
were that the findings be reproducible, using the same 
instrument and technician. No health or safety studies 
were undertaken before it was promoted for general us-
age by the medical community. Nor was there concern 
about compression of the breast, known at the time to risk 
rupture of an already formed tumor, causing metastasis. 
The fact that X-ray exposure caused breast cancer was not 
widely known until the late 1970s.1
Mammography programs gradually spread geographi-
cally since that time, although some in the medical research 
community have been opposed to their widespread use for 
screening (not for diagnosis) from the beginning. The root 
cause of suspicion about the use of mammography has been 
that they expose the breast tissue to x-radiation, which 
to this date is the only proven cause of breast cancer. The 
counter argument has been that early detection of breast 
cancer prevents breast cancer death; therefore, any breast 
cancers that are caused by the x-ray will be detected early 
and “cured,” if the woman stays in the program. Unfor-
tunately, both of these theories appear to be false, given 
the new understanding of the biophysical cause of most 
breast cancers, suggesting that up to 95 percent of cancers 
are casued by subatomic activity triggered by radiation or 
exposure to environmental toxins (Wood-Smith). 
In this paper I will discuss new findings as to the underly-
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ing cause of breast cancer (and other cancers), and the new 
light that this shines on old “truths” about diagnosis and 
treatments. This new finding supposes an understanding 
of the sub-atomic structure of matter (quantum physics), 
an area where direct observation is impossible and one 
must use indirect methods for demonstrating that the 
new understanding is accurate. These indirect methods 
include the ability to diagnose breast cancer using the 
theory, and the ability to prescribe and predict treatment 
outcomes that are medically successful. This new theory 
has proven accurate so far in both of these aspects. Women 
will be glad to know that under this new understanding 
of breast cancer’s cause and treatment, neither the bio-
chemical approach to a cure, using chemotherapy with 
its devastating side effects, nor radiation therapy, which 
can induce new cancers as well as cause cardiovascular 
diseases, are needed for detection or treatment of up to 95 
percent of breast cancers. Although I need to talk about 
findings in biophysics, I will try to use familiar terms and 
understandable science.
Relevant Findings in Quantum Physics 
 
Most people have learned about the atomic structure, 
namely that the atom is composed of electrically nega-
tive electrons and an equal number of electrically positive 
protons. All atoms except hydrogen also contain neutrons, 
which are electrically neutral. Having equal positive and 
negative charges, all atoms are therefore electrically neutral 
by nature. Atoms combined into molecules make up all 
living and non-living material in our universe. 
In 1915, Niels Bohr proposed a deeper structural 
model for the atom, based on the solar system. It was 
observed that the electrons moved in “shells” with spe-
cific energy around the nucleus, and the energy existed 
in quanta, i.e., the electron could move between the 
adjoining shells by gaining or losing exactly one quanta 
of energy. This has led to the name Quantum Theory, 
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or more specifically, Quantum Mechanics, as the study 
of motion in this extremely small sub-atomic domain. 
Further research in the 1960s established as factual that 
the proton and neutron contain smaller particles, called 
quarks, arranged in orderly fashion and in constant 
motion. The ‘new’ atom was found to consist mostly 
of empty space. 
It is difficult to get a mental picture of the atom, but 
thinking about the solar system with planets both spin-
ning on an axis and moving in their orbits around the 
sun, is a good start. The atom is mostly energy, with its 
of electric particle ‘gravity photons’ and harmonizing their 
findings with classical and quantum physics. They have 
also derived theories based on this new understanding 
which elucidate some of the most difficult-to-treat modern 
diseases, including cancer, and have paused in their work 
in physics to communicate these health-related findings 
to inform medical personnel, and enhance their power to 
heal (Wood-Smith).2
In 1994, Robert Wood-Smith predicted that the elec-
tron was energized by extremely small partial electrical 
charges that he called quarkels (small quarks), calling 
“size” determined by the constant motion of the atomic 
and sub-atomic particles, just as a human can take up 
more space by spinning an object around him/her self so 
that no one can get close without an encounter with the 
moving object. 
Taking one step further into this subatomic realm, and 
imagining that within the electron itself, and the quarks, 
which make up protons and neutrons, there are even 
smaller particles, which we will call ‘gravity photons’, 
moving constantly with extremely small electric particle 
‘field energy,’ we have grasped the newest picture of the 
atom. In summary, this new theory posits extremely small 
electric particles, ‘gravity photons’, the electric energy 
of which makes up quarks (components of protons and 
neutrons) and electrons. The electric energy of ‘gravity 
photons’ is constantly moving within a tightly defined 
space-time standing wave. These ‘gravity photons’ form 
the fundamental particles giving rise to the electrical 
energy of quarks, protons, neutrons and electrons, which 
in turn form atoms and molecules. This is a very new 
understanding of atoms, available to only a small number 
of scientists since about 1994, and its implications are 
not widely known or understood. Intact atoms are the 
smallest unit of all chemical and biochemical reactions, 
while the ‘gravity photon’ electric particles form a digital 
bioelectric communication system, within or below the 
chemical system, important in maintaining healthy living 
tissue, organs and the whole intact living being.
How Do We Know This Is a True Picture of the 
Atom? 
Robert Wood-Smith, with the collaboration of an in-
dependent scientist Albert Mantiziba, is responsible for 
developing the equations and quantification of this theory 
attention to the importance of investigating the sub-
atomic levels of activity. The 1998 Nobel Prize in Physics 
was awarded to three scientists in the United States, for 
their discovery that the electron had components. This 
was confirmation of the existence, but not the nature 
of the quarkels.
Science magazine in 1996 reported that American 
researchers have said they found that collisions between 
quarks in a particle accelerator were unexpectedly vio-
lent. William Carithers, of Fermi National Accelerator 
Laboratory, in Batavia, Illinois, told Science: “This is 
just the sort of effect you would see if quarks were not 
fundamental particles, but had some sort of internal 
structure” (Glanz 758).3 The 1997 article in New Scientist 
reported the results from desy, the German Electron 
Synchrotron, that pointed to the existence within the 
electron of what is described as a “leptoquark,” previ-
ously called a quarkel by Robert Wood-Smith (Muir 
“Science” 14). These small particles are only beginning 
to be understood by scientists. 
Nature of These Sub-atomic Electrical Particles 
Called ‘Gravity Photons’ 
The ‘gravity photon’ is seen as a waveform. It needs to 
be understood that the waveform (i.e., a wavelength) is 
a ‘profile’ indicating the pathway of an ‘electric particle’ 
(with a partial charge) consisting of gravitational energy. 
Researchers assumed that for electromagnetic photons the 
length of the wave form or ‘profile’ was the ‘size’ of the 
particle. However, experiments conducted by a team led by 
Thomas Ebbesen of the Louis Pasteur University in Paris 
and the nec Research Unit in Princeton, New Jersey, have 
shown that light could be transmitted through “quantum 
cavities” with “100 per cent efficiency at a wavelength 
One of the most difficult medical problems today is the growing 
toxicity of chemotherapy needed to overcome breast cancer. The 
treatment involves the most toxic of pharmaceutical medicines and the 
most extreme of radiation therapies, but even with this all-out 
assault on the breast tissue, the disease is often fatal.
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ten times bigger than the diameter of the hole” (Chown 
667).4 This suggests that the waveform (i.e. wavelength) 
is being formed by a small enough ‘particle of electric 
energy’ which, according to Ebbesen, would be able to 
“get 1000-nanometre light through 150-nanometre holes” 
(Chown 669).
The former ‘theory’ that the photon has an effective size 
equal to its wavelength no longer stands. A wavelength 
may now be understood to result from a ‘particle of energy’ 
(the fundamental photon) being displaced by its waveform 
over a distance in-time. The length of that displacement-
in-time will determine the characteristic presented by 
the energy—a reality demonstrated by the study of the 
various frequencies that comprise the photons of the 
electromagnetic spectrum. These variable characteristics 
are now used to form radio waves, microwaves, infrared, 
visible light, ultraviolet light and x-ray, gamma rays and 
cosmic photons, likely also electricity.
Modern Medicine is Based Largely on Biochemistry
Mendeleev’s Principles of Chemistry was first translated 
into English in 1891. His Periodic Table facilitated an 
understanding of the chemical basis of living beings and 
made chemistry the most advanced of the sciences at the 
turn of the twentieth century. At the time, the bioelectric 
properties of the human body were recognized, but their 
mechanisms were not understood, and many dubious 
electrical experimental treatments were being practiced 
by doctors, some bordering on quackery.
In 1910, the Flexner Report was issued to reform 
medical education in North America and at the same 
time, to bring it into the mainstream of scientific meth-
odology. University medical education adopted the sci-
entific method that was thoroughly grounded in human 
anatomy, physiology and biochemistry. Unfortunately, 
to curb the excesses in bogus electrical treatments, the 
Report banned the use of biophysical treatments “until 
there was a thorough understanding of the underlying 
science” (Flexner 1910). Subsequently, biophysics was 
dropped in most medical curricula, and the medical 
profession began to depend only on pharmaceuticals 
(chemicals) and vaccines (chemicals) to solve all medical 
problems. As was noted, chemicals work on the atomic 
and molecular level, but are ineffective when the sub-
atomic level is abnormal. Looking back, we see that 
during the past century great strides in understanding 
the fundamentals of physics have been made, yet the 
medical community is ill prepared to understand, let 
alone use, this new knowledge.
Medicine has progressed greatly, but it is still unable to 
treat or treat successfully many antibiotic resistent infec-
tions, cancer, and various other illnesses like Alzheimer’s, 
Parkinson’s disease, and aids, which resist pharmaceutical 
treatment. Some cancers have been successfully treated with 
x-radiation, although this treatment also has unwanted 
side effects. As a class, these diseases exhibit non- or miss-
communication properties, relative to the human body’s 
immune system (which fails to destroy them as “foreign”) 
and standard (normal) medicines (which fail to work as 
expected). These difficult or seemingly impossible to treat 
pathologies can be expected to benefit most from a deeper 
understanding of the subatomic electric particle theory.
The commonality in these diverse pathologies is the 
non- or miss-communication between the body’s immune 
system and normal medicines with the pathogen. In this 
context, the new understanding of the electric particle ‘field 
energy’ generated by the ‘gravity photons’ within quarks 
and electrons of the atoms, is that the photon vibrations 
(moving within a standing wave) have slowed to a speed 
less than the speed of light c, that is, they are vibrating 
at less than the normal speed applying to the atoms of 
matter on this planet. Most people have experienced 
the non- or miss-communication or garbled message of 
a digital transmission which is played at a slower than 
normal speed. This is similar.
What could have caused the slowing down of the 
primordial motion of the ‘gravity photons’ in previously 
healthy tissue? The only known particles on our earth 
which have the electric particle ‘field energy’ slower than 
the speed of light c, are particles of radioactivity—alpha, 
beta and gamma particles—violently exploded from the 
nucleus of unstable chemical elements which either occur 
naturally or are artificially produced in a nuclear reactor 
or nuclear explosion. 
The slower moving electrical photon energy of the radio-
activity—alpha, beta, and/or gamma particles—can come 
into direct contact or close vicinity of atoms in the dna 
within cells of living tissues (this applies also to proteins, 
bacteria, and viruses, in plants, animals or humans). The 
affected dna can begin to propogate electrically abnormal 
pathogenic cells. The normal vibrations, within some of 
the tissue’s cellular atoms, can begin to move in-sync with 
the abnormal vibration of the electric particle ‘field energy’ 
within atoms of the ‘abnormal dna’—some whole cells 
becoming ‘abnomal cells’, that is, out-of-sync within the 
natural tissue environment. One such series of changed 
cells is referred to as a cancer. 
This problem is made worse by the various chemical 
hazards in the environment, which can destroy the natural 
immunity to background radiation in the environment, es-
pecially of the dna within cells.5 Once a sufficient number 
of cells become ‘abnormal’, this abnormal slower moving 
‘field energy’ forms characteristic abnormalities associated 
with the various electrical energy related pathologies called 
‘radiosensitive’, since they respond to energy treatment by 
electrical particle ‘field energy’ at the speed of light c. This 
phenomenon has been recently called genomic instability. 
It appears to be involved also in the mysterious ‘bystander 
effect’ by which cells not directly affected by radiation, but 
near to the affected cells, can also develop malignancies 
or other pathologies.
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Implications for Breast Cancer
One of the most difficult medical problems facing doctors 
today is the growing toxicity of chemotherapy needed to 
overcome breast cancer. The treatment involves the most 
toxic of pharmaceutical medicines and the most extreme 
of radiation therapies, but even with this all-out assault on 
the breast tissue, the disease is often fatal. Understanding 
of the abnormally slow ‘field energy’ of this pathology 
(in up to 95 percent of cases, as observed in Europe and 
North America) leads to remedies which raise the energy 
abnormal radioactive particle to harmonize its electri-
cal particle ‘field energy’ with that of the radioactive 
particle.
It is scientifically feasible that the loading of toxic 
chemicals now in our environment has undermined the 
natural ability of the body to resist the background radia-
tion hazard. This natural resistance ability, perhaps due to 
greater opportunity for absorption and accumulation of 
toxic chemicals, may also decline with chronological age, 
since, historically, most cancers have occurred in old age.
level of the radiosensitive tissue, so that the message of 
the electrically abnormal (radiosensitive) cancerous tissue 
can be ‘read’ by the body’s immune system and thereby 
marked for destruction by the immune system. Normal 
tissue, already operating with ‘field energy’ at the speed 
of light c, will not be affected by this therapy.
Diagnosis
In an American clinical trial involving 463 women (100 
of whom were known to have breast cancer), the Biofield 
Diagnostic System scanner, which records the low electri-
cal particle ‘field energy’ characteristics of tissue, was able 
to select and identify 95 percent of women with known 
breast cancer as having slower than normal ‘field energy’, 
i.e., as being radiosensitive. In this test, two metal discs 
are placed on the breast, and the electrical differential 
between the two is measured. There is no compression 
of the breast needed. The results confirmed that most 
breast cancers in this u.s. trial were distinguished by 
electric particle ‘field energy’ which was moving slower 
than normal ‘field energy’ of the speed of light c. Such 
an abnormal state would have required the following 
three conditions:
•Loss of normal protection of the dna against natural 
background radiation, since radioactive particles are 
the only particles on earth known to have an abnor-
mally slow electric particle ‘field energy’
•Exposure to such abnormal background radia-
tion either from a natural source, a technologically 
enhanced natural sources (like uranium mining 
debris), or fission/activation products from nuclear 
reaction activities 
•And the ability for tissue in close contact with an 
These slow electric particle ‘field energy’ breast cancers 
(up to 95 percent of the total in the u.s. trial referred to 
above) are precisely the breast cancers caused by exposure 
to radioactive particles (alpha, beta and/or gamma particles) 
known to have slower electric particle ‘field energy’ than 
the speed of light c. The five percent or more of the breast 
cancers which that do not exhibit a slower than normal 
electric particle ‘field energy’, are the result of ionization 
or genetic inheritance, and will require different treatment 
than is discussed in this paper.6
The Biofield Diagnostic System scanner is designed to 
replace the mammography machines.7 It is more efficient 
in recognizing radiosensitive cancers than mammogra-
phy, ultra sound or physical examination.8 It is also able 
to diagnose about 30 percent of those breast cancers in 
younger women with dense breasts, which are usually 
missed by mammography.
The Biofield Diagnostic System scanner can successfully 
distinguish between those breast cancers which will respond 
to electric particle energy treatment (commonly up to 95 
percent, less in some countries), with photoelectric or low 
intensity microwave treatment, and those which require 
different treatment (commonly five percent or more). It 
does not require compression of the breast, and does not 
itself cause breast cancer.
Biofield Corp., with headquarters in King of Prussia, 
pa, and the MacKay Group recently established a Chinese 
national healthcare joint venture built around Biofield’s 
breast cancer diagnostic device. MacKay has been backing 
Biofield since 2004. The Joint Venture (jv) will be called 
Worldwide Lifecare Limited or the Carelife jv because 
the agreement is between Biofield and Carelife, which is 
operating through its appointed agent, China International 
Exchange Ltd. Funded with approximately $363 million, 
the Carelife jv has opened a China network of medical 
The Trimprob analyzes the condition of tissues and organs in real time, 
detects and localizes radiosensitive pathologies and finds them at a 
very early stage. It can be used while patients are dressed and comfortable, 
and offers immediate results with a high degree of effectiveness.
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clinics, call centers and data centers for research and devel-
opment. The first medical clinic opened in October 2008, 
at Carelife’s Headquarters in Shanghai. By 2012, Carelife 
expects to open more than 500 medical clinics in China’s 
major cities, which will make the jv’s technology available 
to a 60 percent share of China’s urban population. The jv 
includes, as a partner, China’s National Labor Union, and 
it is funded with an investment by the Chinese Govern-
ment. The 500 medical centers will open in Labor Union 
centers. China’s major insurance carriers have agreed to 
refer their clients to the centers. 
On 12 June 2003, a similar instrument, the Trimprob, 
was introduced at the San Carlo Borromeo Hospital and 
the European Institute of Oncology, in Milan, Italy.9 The 
Trimprobe is able to detect a variation in electromagnetic 
wavelengths between healthy tissue and cancerous tissues. 
Breast cancers formed by slower than normal electric 
particle ‘field energy’ resonate around 400 megahertz, 
while healthy (normal for particle electric ‘field energy’) 
breast tissue resonates at 1350 megahertz. Therefore, 
Trimprobe is capable of identifying up to 95 percent of 
radiosensitive breast cancers. The Trimprob analyzes the 
condition of tissues and organs in real time, detects and 
localizes radiosensitive pathologies ranging from inflam-
matory conditions to cancers and, most importantly, finds 
them at a very early stage. It can be used while patients 
are dressed and comfortable, and offers immediate results 
with a high degree of effectiveness. 
Trimprob contains an antenna that generates an elec-
tromagnetic field at very low power, much less than that 
of a cell-phone, interacting with tissues at the submicro-
scopic level. A computer linked to the probe analyzes 
the amount of interference at different frequencies and 
displays results in real time in an easily understandable 
graphical format.
The Biofield Diagnostic System scanner and the Trim-
prob are consistent with the theory put forth by Robert 
Wood-Smith and explained here. Additionally, they 
help to confirm this new understanding of the deeper 
subatomic problem underlying most cancers, including 
breast cancer.
Treatment 
The tumors that are characterized by slower moving electric 
particle ‘field energy’ within the atoms of diseased tissues 
will respond to high or low frequency electric particle 
‘field energy’ at the speed of light c. This accounts, for 
example, for the observation that x-ray therapy has been 
widely recognized as capable of treating cancer. However, 
the mechanism by which the radiotherapy success occurs 
has not been well understood. Furthermore, the use of 
high frequency electric particle ‘field energy’ can cause 
ionization and do severe damage to nearby healthy tissue. 
By using lower frequency electric particle ‘field energy’ 
at the speed of light c, which will not damage healthy 
tissue by ionization, much of this collateral damage can 
be avoided. 
The new understanding of the mechanism which un-
derlies the success of the proposed alternative treatment is 
that an appropriate input of electric particle ‘field energy’ 
at the speed of light c, can cause the ‘field energy’ in the 
radiosensitive tumor to be brought up gradually to that of 
normal tissues. Care is, of course, taken to avoid heating 
the tissue to the point of killing the healthy cells, or pro-
longing treatment so as to cause any other electromagnetic 
damage to normal tissue. 
When the electric particle ‘field energy’ of the cancerous 
tissue has been normalized in ‘field energy,’ the “message” 
carried by the dna of the tumor can be understood by the 
body’s immune system and the cells can ‘communicate’ 
with other pharmaceutical treatments or be marked as 
pathogenic for destruction by the immune system. This 
is not a matter of “killing” the cancer cells either by heat 
or high frequency energy damage.
Examples of Treating Cancer Successfully
Seven years ago, Dr. David Lloyd, consultant liver surgeon 
at the Leicester Royal Infirmary and clinical tutor in surgery 
at the University of Leicester Medical School, in the uk, 
came up with the idea of placing a tiny probe into liver 
tumors to irradiate them with microwaves. To date, more 
then 100 patients diagnosed with inoperable terminal 
liver cancer have been treated with the technique, often 
in combination with chemotherapy, and in 95 percent of 
these patients the cancer disappeared (“Life-saving”). One 
of these patients, Maureen Horney from Sussex, said:
When I was first diagnosed with liver cancer I con-
tacted the Mayo Clinic in America for advice and 
doctors told me my tumors were untreatable. They 
gave me a maximum of six months to live. I then 
found out about Dr. Lloyd’s unique microwave probe 
and I am now alive and well - four years after being 
diagnosed with inoperable cancer. (“Life-saving”)
According to Dr Lloyd:
The microwave machine which has been developed 
at uhl can treat very large tumors within a few min-
utes. I have now treated nearly 100 patients and over 
200 cancers. The microwave device is extremely safe, 
very effective and easy to use and is proving to be a 
significant advance in the treatment of liver cancer. 
(“Life-saving”)
The microwave treatment has attracted attention from 
experts worldwide, so much so that Dr Lloyd has been 
asked to talk about the ground-breaking treatment at 
a number of international meetings. Dr Lloyd has ad-
dressed the Prime Minister of Malaysia, where liver 
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cancer is endemic, the American Congress of Surgeons, 
the European Hepatbobiliary Association, and the World 
Congress of Liver Surgery meeting in Las Vegas, usa, in 
September 2007. 
This same method could be used for breast cancer in 
cases where the tumors are sufficient in size for insertion 
of a small metal probe. Most recently, the Oklahoma 
University Cancer Institute in the usa has introduced 
‘focused microwave thermotherapy’ for the treatment 
of breast cancer, which is said to reduce the number of 
women needing a breast removed by up to 90 per cent 
(“Breakthrough”). This research is in the early stages, and I 
would assume from the use of the word “thermo” that the 
researchers think they are seeing a thermal effect, which in 
due course is likely to be viewed as a mistake. However, 
understanding the vibrational effect of microwave on sub-
atomic particles is a very new concept, which may not yet 
have become available for study by these researchers.
The Indiba md-308 is another instrument being used 
for low energy ‘electric field’ treatment for tissue with 
slower than normal electric particle ‘energy field’. It is 
a non-invasive instrument utilizing 200 watts over 50 
ohms, at 500 kHz. Indiba medical equipment has been 
used extensively by Dr. Adolfo Ley-Valle from Barcelona, 
and it has a respected safety record (Ley-Valle).
Light itself can be used to treat successfully radiosensitive 
cancers (that is, those cancers with slower than normal 
electric particle ‘field energy’) on the surface of the skin, or 
within the lungs, where in either case there is easy access 
to apply the treatment known as Photodynamic Therapy 
(pdt) (“Photodynamic” ). After sensitizing the skin cancer 
to light, followed by irradiation with a suitable wavelength 
of laser light, which is comprised of electric particle ‘field 
energy’ at the speed of light c, the slower moving electric 
particle ‘field energy’ of the atoms of the cancer cells be-
comes elevated in ‘field energy’ speed towards the ‘normal’ 
electric particle ‘field energy’ speed of light c.
Dr. Jeremy George of University College London Hos-
pital has utilized pdt to treat lung cancer with success. 
A camera is inserted into the lungs of the cancer patient 
together with a blue light suitable for detecting tumors. 
Normal lung tissue will reflect back the bluish light; 
however, the cancer tissue, with the slower electric particle 
‘field energy’ speed, will induce the red/mauve spectrum 
of visible light. In this way the tumors become easily 
identifiable to the doctor treating the patient. Interestingly, 
blue laser light is also being used during cancer surgery to 
check the edges of removed tissue to see whether or not 
all cancerous tissue has been removed.
When the electric particle ‘field energy’ of the ‘base 
pair’ atoms comprising the dna of the cancer cell has 
been elevated to the normal ‘field energy’ speed of the 
electromagnetic spectrum, the body is able to: 
•decode the information associated with the cell
•recognize the cancer cell as foreign and
•mark the cell, to be destroyed by the immune 
system. 
Summary
The new designation, ‘radiosensitive cancers’, has been 
given to those cancers that can be treated successfully 
with an appropriate application of electric particle ‘field 
energy’ at the speed of light c. These cancers reflect a 
condition, where the electric particle ‘field energy’ of a 
substantial number of atoms comprising the cells of the 
tumor, operate at a speed which is slower moving than 
the ‘normal’ speed of light c. The latter normal speed is 
the ‘field energy’ speed shared by all of the frequencies 
of the electromagnetic spectrum, i.e. the speed of light c. 
Those cancers that are not radiosensitive are being called 
radioresistant. They have normal electric particle ‘field 
energy,’ and are formed through ionization or genetic 
inheritance. Their electric particle ‘field energy’ is that of 
the speed of light c.
The Future
Obviously, this brief glimpse at a new understanding of 
the subatomic abnormality of most breast cancers, their 
diagnosis and treatment, based on a new understanding 
of subatomic physics, cannot answer all questions which 
the reader might have. There will be many more useful 
insights developed, clarifying the genesis and treatment of 
other cancers and diseases which that resist today’s medical 
treatment modalities. 
What is most needed now is openness on the part of 
the medical regulators and clinical physicians to allow for 
guided experimentation with this most promising medical 
breakthrough. Robert Wood-Smith stands ready to help 
those who wish such guidance, asking only for his out-of-
pocket expenses. It should make sense to have a knowledge-
able physicist, who has discovered this mechanism, guide 
the experiments to utilize this knowledge for its healing 
potential. Double-blind clinical trials need to be launched 
and women need to be helped to realize that breast cancer 
need not be the scourge which burdens families with years 
of suffering and cuts short women’s lives. 
There are also implications for the nuclear commercial 
and weapon industries that could not be sufficiently 
fleshed out here. Radiation Protection Standards, set on 
the assumption that the only radiation related cancers were 
those due to ionization will need to be updated to account 
for the inordinate effect of internal contamination with 
unstable atoms which emit particles with slower electric 
particle ‘field energy’ than that of normal living cells. This 
subatomic vibrational effect of radioactive alpha, beta and 
gamma particles was not foreseen by those who set the 
radiation standards in 1950 (Mayneord)!
Future research will need to apply this new understand-
ing of radioactive particle affects to proteins, bacteria and 
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viruses, and to intra and intercellular communication in 
higher organisms, including animals and humans. This 
new understanding will require profound examination 
of long accepted radiation protection policies, especially 
for internal exposures, which are now known to be non-
protective of living things.
While new avenues of healing are opened up, old coun-
terproductive policies must be changed: both changes will 
have significant effects on the lives of ordinary people. We 
can expect these changes to take place at different rates 
geographically and in time, but they give hope of a much 
healthier future for the living beings on planet Earth.
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1See a special forum on the radiation effects controversy 
in The Bulletin of the Atomic Scientists (Tamplin and 
Gofman 1970).
2A free electronic copy of Robert Wood-Smith’s report is 
available at fundamental_physics@talktalk.net
3See also Heather Muir’s 1996 article in New Scientist 
(“Heart”).
4For a full report on this discovery, see Ebbesen et al.
5There are about three billion base pair in the human 
dna, which carry the genetic information and triggers. 
Some are affected by interaction with toxic chemicals 
endemic in our environment which singly or in combina-
tions expose the dna to low-level radioactivity within the 
natural environment. 
6The treatment of these radioresistant cancers is beyond 
the scope of my present discussion and would require a 
separate paper.
7The Biofield Diagnostic System has been developed and 
tested by the world’s leading breast cancer specialists. It 
has been developed to make mammograms and all other 
current breast cancer diagnostic technologies obsolete in 
the next generation. Biofield Corp., currently partnering 
with MacKay Life Sciences, is located in King of Prussia, 
PA. [King of Prussia Business Center, Suite C, 1019 West 
Ninth Ave., King of Prussia, pa, United States.]
8Physical examination of the breast has 71-80 percent 
sensitivity and 20-40 percent specificity; ultrasound has 
60-80 percent sensitivity and 34-74 percent specificity; 
diagnostic mammography has 78-90 percent sensitivity 
and 20-40 percent specificity; Biofield has 90-95 percent 
sensitivity and 40-65 percent specificity. Only Biofield 
Diagnostic System and Trimprob provide objective in-
formation on breast cancer.
9On 21 July 2003, Trimprob, Tissue Resonance Interac-
tion Method, a hand-held, portable, quick, non invasive 
cancer detection tool was introduced in the United States 
at a Washington d.c. press conference. Similar to a metal 
detector used to frisk airline passengers, Trimprob is a 
light-weight (1.3 pounds) plastic baton that produces a 
beam of microwaves. It is based on patented technology 
discovered in Italy by physicist Clarbruno Vedruccio and 
developed by a defense company Galileo Avionica, a sub-
sidiary of Finmeccanica S.p.A., Italy’s largest defense and 
aerospace group with annual revenues of approximately 
$8.5 billion.
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MARY TRAFFORD
welcome to cancerland
Inspired by an article by 
Barbara Ehrenreich
you were warned:
maybe if you’d been more careful
this wouldn’t’ve happened
though I/you/they/we
will never know which
noxious substance / faulty gene / toxic 
chemical
pesticide/ herbicide/vaccine/drug / or if
a childhood spent in second- and third-hand 
smoke
(or that Export A you stole at age 10
from your sleeping uncle’s pocket, smoked
with your cousin in the bathroom
even though the window was open, maybe 
that)
started it all




that never lets go
welcome to cancerland, little girl
now sit still
while I chew your leg off.
A two-time cancer survivor living in Chelsea, Quebec, 
Mary Trafford Draws poetic inspiration from teammates 
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